2023 ASTRO Annual Refresher Course onDemand

This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most major sub-disciplines of radiation oncology, including sarcomas, pediatrics and lymphomas, and the role of radiotherapy in the multidisciplinary management of cancer patients. The course will review key evidence that forms the basis for current clinical practice guidelines and trends in new approaches. In addition, the course will cover implementation of hypofractionation in key disease sites as well as treatment of oligometastases and use of SBRT to improve outcomes for patients with metastatic disease. It will also provide hands-on experience in contouring for lung, prostate and liver. It will also inform on the emerging field of theranostics and the use of radiopharmaceuticals in the treatment of select patients with cancer.

Target Audience

The activity is designed to meet the interests of radiation oncologists and radiation oncology residents.

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

  • Describe and implement the latest radiation therapy treatment recommendations for clinical scenarios commonly encountered in clinical practice.
  • Safely utilize the latest radiation technologies to improve patient care.
  • Incorporate hypofractionation into appropriate disease sites.
  • Appropriately and safely incorporate the treatment of oligometastases into clinical practice.
  • Describe the value of radiopharmaceuticals in the care of patients with cancer and the role that radiation oncologists may have in this practice.

 

Course summary
Available credit: 
  • 22.75 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 22.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 22.75 Certificate of Attendance
    This activity was designated for 22.75 AMA PRA Category 1 Credit™.
Course opens: 
02/15/2023
Course expires: 
05/07/2025
Cost:
$899.00
Rating: 
5

Below are the faculty disclosures for the 2023 ASTRO Annual Refresher Course. All relevant financial relationships have been mitigated.

Additionally, Annual Refresher Course Steering Committee had control over the content of this activity.

2023 Annual Refresher Course

First Name

Last Name

Employment

Compensation/Remuneration

Funding

 

Ownership/Investment Interests

 

Leadership Position

 

Safia

Ahmed

Mayo Clinic: Assistant Professor, Radiation Oncologist: Employee

 

None

None

None

Megan

Daly

University of California Davis: Professor of Clinical Radiation Oncology: Employee

Astra Zeneca: Honoraria: Relationship ended; Curio: Honoraria: Relationship ended; Dava : Honoraria : Relationship ended ; EMD Serono : Grant/research funding : Relationship ended ; Genentech : Grant/research funding : Relationship ended ; Merck : Grant/research funding : Relationship ended ; Novocure : Honoraria : Relationship ended

None

Clinical Lung Cancer: Editorial board member: Radiation oncology editor for CLC journal; IJROBP: Associate Editor: Member of thoracic team

Alexandra

Diaz

The Ohio State University: Associate Professor: Employee

ASCO: Honoraria: Relationship ended

None

The Ohio State University: Vice-Chair of DEI: I am the Vice-Chair of DEI

William

Hall

Medical College of Wisconsin: Associate Professor: Employee

Aktis Oncology: Compensation/Payment: Relationship ended; Elekta AB, Stockholm, Sweden: Grant/research funding: Relationship ended

None

None

Lara

Hathout

Rutgers Cancer Institute of New Jersey: Associate Professor: Employee

RTOG Foundation: Compensation/Payment: Relationship ended

None

None

Robert

Hobbs

None

AA/Novartis: Honoraria: Relationship ended

RAPID Dosimetry: Copyright/Patent/License/Royalty

AAPM: Chair of Radiopharmaceutical Therapy Sub-Committee: see title

Karen

Hoffman

MD Anderson Cancer Center: Professor: Employee

Janssen: Grant/research funding: Relationship ended; Varian Medical Systems: Grant/research funding: Relationship ended

None

None

Bradford

Hoppe

Mayo Clinic: Professor of Radiation Oncology: Employee

Merck: Children's Oncology Group funds my scientific advisory board work into a Mayo research PAU: Relationship ended

None

NRG lymphoma working group: Co-Chair: co-chair; PTCOG: Secretary: secretary

Salma

Jabbour

Rutgers University: M.D.: Employee

Beigene : Grant/research funding : Relationship ended ; IMX Medical : Compensation/Payment : Relationship ended ; Merck & Co, Inc : Grant/research funding : Relationship ended ; Novocure : Compensation/Payment : Relationship ended ; Radialogica : Compensation/Payment : Relationship ended ; Syntactx : Compensation/Payment : Relationship ended

None

IJROBP Deputy Editor: Deputy Editor: edit articles for IJROBP

Mitchell

Kamrava

Cedars Sinai: Associate Professor: Employee

Alessa: Compensation/Payment: Relationship ended; GammaTile: Compensation/Payment: Relationship ended; Springer: Compensation/Payment: Relationship ended; theragenics : Honoraria : Relationship ended

None

ABR Gyn examiner: ABR Gyn oral examiner: ABR Gyn oral examiner; ABS: Board of Directors, Member-at-large: Board of Directors, Member-at-large; ADROP: President: ADROP President

Jordan

Kharofa

University of Cincinnati: Associate Professor: Employee

None

None

None

Ana

Kiess

Johns Hopkins University: Associate Professor: Employee

Bayer: Grant/research funding: Relationship ended; Merck: Grant/research funding: Relationship ended; Novartis/AAA: Grant/research funding: Relationship ended; POINT: Uncompensated: Relationship ended

None

American Board of Radiology: Oral Board Examiner/ Section member: Volunteer member of head and neck/ skin section for Oral Board exam content development and oral examiner

John

Lucas

St. Jude Children's Research Hospital: Associate Member: Employee

Children's Cancer and Leukaemia Group - CCLG: Uncompensated: Relationship ended; International PPB/DICER1 Registry: Uncompensated: Relationship ended; Malaysian Society of Paediatric Haem & Onc : Uncompensated : Relationship ended ; Philips : Uncompensated : Relationship ended

None

ASTRO Scientific Committee - Pediatric section : Pediatric Section Chair : Devise and review the educational content of the meeting.; Global Neuroblastoma Network : Radiation panel lead : Consult on international cases and generate educational content.; Pediatric Cancer Data Commons - NODAL & REACH : Executive committee member : Provide input on projects and review data sharing agreements and project proposals; St. Jude Children's Research Hospital Continuing Medical Education (CME) Committee : Member : Construct content for the organization.

Jelena

Lukovic

Princess Margaret Cancer Centre: Radiation Oncologist: Employee

None

None

None

Raymond

Mak

Brigham and Women's Hospital: Associate Professor: Employee

AstraZeneca: Honoraria: Relationship ended; Novartis: Honoraria: Relationship ended; Sio Capital Mgmt : Honoraria : Relationship ended ; Varian Medical Systems : Honoraria : Relationship ended ; ViewRay : Grant/research funding : Relationship ended

HealthAI : Ownership equity : Relationship ended 12/31/2022

None

David

Palma

London Health Sciences Centre: Radiation Oncologist: Independent Contractor

Need Inc: Honoraria: Relationship ended; UptoDate.com: Honoraria: Relationship ended

Need Inc: Stock

None

Manisha

Palta

Duke University: Associate Professor: Employee

Merck: Grant/research funding: Relationship ended

None

ASCO GI Cancers Symposium Leadership Committee: Planning Committee: Planning committee for GI ASCO meetings

Mylin

Torres

Emory University: Professor: Employee

Genentech: Grant/research funding: Relationship ended; NCI: Grant/research funding: Relationship ended ; Oncohealth : Compensation/Payment : Relationship ended ; Pfizer : Grant/research funding : Relationship ended ; Varian : Compensation/Payment : Relationship ended

None

None

Phuoc

Tran

University of Maryland School of Medicine: Professor & Vice Chair: Employee

Bayer Healthcare: Honoraria: Relationship ended ; Janssen : Honoraria : Relationship ended ; Natsar Pharmaceuticals : Honoraria : Relationship ended ; RefleXion Medical Inc : Honoraria : Relationship ended

Natsar Pharmaceuticals: Copyright/Patent/License/Royalty

AACR: Radiation Science and Medicine Working Group Steering Committee: Member; Cancer Research : Senior Editor : Senior Editor; Journal of Clinical Oncology : Editorial Board : Editorial Board; NRG Oncology : GU TS Chair : GU TS Chair

Christina

Tsien

McGill University: Professor: Employee

Novocure: Compensation/Payment: Relationship ended

None

 

Gayle

Woloschak

None

None

None

None

Sue

Yom

None

None

None

None

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

Available Credit

  • 22.75 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 22.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 22.75 Certificate of Attendance
    This activity was designated for 22.75 AMA PRA Category 1 Credit™.
 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
Please login or register to take this course.
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
Please login or register to take this course.
$0.00Included
$0.00Included
$0.00Included
$0.00Included

Price

Cost:
$899.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

  •     Nonmember: $899
  •     Member: $699
     

Policies:
No refunds, extensions, or substitutions will be made for those registrants. Including those who for any reason,  have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the ASTRO website for that 2 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.”

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.